Vectura Group has appointed its Chief Operations Officer, Dr Trevor Phillips, onto the Board of Directors.
Trevor Phillips joined Vectura as President of US Operations in 2010, becoming COO in July 2011.
Before joining Vectura, he gained extensive international experience in pharmaceutical company leadership and drug development, including the roles of COO and CEO at US company Critical Therapeutics as well as senior positions at Sepracor, Accenture and GlaxoWellcome.
Jack Cashman, Chairman of Vectura, commented: “We welcome Trevor’s addition to the Board, where his extensive industry experience in both European and US public listed pharmaceutical companies will be an asset to us as we evolve on the next stage of growth, positioning ourselves as a key player in the respiratory market.”
Based in Chippenham, Vectura specialises in developing drugs to treat respiratory diseases.
Share this article: